Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Is The Virus-Induced Stock Selloff Overdone? ETFs To Buy Now

Published 03/12/2020, 02:30 AM
Updated 07/09/2023, 06:31 AM

The coronavirus scare sent the broader market into a tailspin, withthe S&P 500 losing 18.4% in the past month (as of Mar 11, 2020), the Dow Jones losing 19.5% and the Nasdaq Composite retreating 18.4%.

The crisis aggravated on Mar 11 after WHO declared the coronavirus outbreak a global pandemic. To add to the woes, President Trump enacted a month-long travel ban from Europe (except the United Kingdom) to contain the spread of the virus, dealing a blow to global trade. Also, there was no mention of payroll tax cuts that markets were hoping for.

Many market watchers signaled an upcoming recession. Some found similarities between the latest market fallout and the 2008 crisis. But is it true? Probably not. In 2008, the crisis was demand shock-driven and core weakness in the economy. This time, the problem is centered on supply chain and economic picture was almost steady just before the virus attacked.

Will Markets Keep Skidding?

JPMorgan Chase (NYSE:JPM) believes no. Its chief U.S. equity strategist said in a note to clients that “the market has gone ahead and priced in too severe of an adverse scenario, assuming we get timely and strong counter-policy response and a COVID-19 outbreak that peaks in the coming weeks.”

A recession is not inevitable,” says chief economist of PNC Financial Services Group (NYSE:PNC). Even if we have a recession soon, the scale of it would be less severe than the Great Recession, per the economist. “It’s closer to a natural disaster,” per the director of U.S. Macro Investors Services at Oxford Economics.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

JPMorgan said a market sell-off of this scale normally indicates a 65% to 75% chanceof recession in the coming one year. But the economy is now on a strong footing (excluding the impact of virus). Americans’ savings were just 3.6% of their income at the end of 2007, while households now save at an 8% rate. Unemployment rate is at a 50-year low level.

Then there is hope that the summer months may slow down the spread of coronavirus. So, though Great Recession in 2008 lasted 18 months, the latest virus-driven economic slump may stretch for six months, per chief economist of Grant Thornton.

Pent-Up Demand to Boost Markets Once Virus Dies?

With the Fed and the BoE announcing emergency rate cuts, Australia and Hong Kong adopting policy easing and the People's Bank of China (PBOC) is asking banks to “help firms struggling with repayments by extending loans and not penalizing them if they are late with payments,” the extent of coordinated monetary policy easing is understandable (read: Emergency Fed Cut Less Effective: ETFs That Should Survive).

Then there is $50 billion-aid from IMF. President Trump signed an $8.3-billion spending package. The Trump administration is also mulling over extending the Apr 15 tax filing deadline to help support American households and businesses, per CNN. All these fiscal and monetary support should improve the risk/reward of investing, per JPMorgan (read: "At Least 3 Rate Cuts" by December? Sector ETFs to Play).

So, we might see a market rally, thanks to solid pent-up demand. JPMorgan reaffirmed its year-end S&P 500 price target at 3,400, suggesting a rise of 24% from the close on Mar 11.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

ETFs to Pick

Against this backdrop, we highlight a few beaten-down ETFs that offer forward yield greater than 1% (present benchmark treasury yield is 0.82%), have a Zacks Rank #2 (Buy) and Beta in the range of 0.89x to 0.94x.

Health Care Select Sector SPDR ETF (NYSE:XLV) XLV – Down 12.1% in the past month

Beta: 0.92x
Yield: 2.32%

Vanguard Dividend Appreciation ETF (ASX:VIG) – Down 15.7%

Beta: 0.89x
Yield: 1.86%

Principal U.S. Mega-Cap Multi-Factor Index ETF USMC – Down 16.3%

Beta: 0.89x
Yield: 2.19%

iShares Russell 1000 Pure U.S. Revenue ETF AMCA – Down 18.2%

Beta: 0.87x
Yield: 2.64%

iShares Core Dividend Growth ETF DGRO – Down 18.8%

Beta: 0.94x
Yield: 2.45%

Want key ETF info delivered straight to your inbox?

Zacks' free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>



Health Care Select Sector SPDR ETF (XLV): ETF Research Reports

VanEck Vectors Mortgage REIT Income ETF (MORT): ETF Research Reports

iShares Core Dividend Growth ETF (DGRO): ETF Research Reports

Vanguard Dividend Appreciation ETF (VIG): ETF Research Reports

Principal U.S. Mega-Cap Multi-Factor Index ETF (USMC): ETF Research Reports

iShares Russell 1000 Pure U.S. Revenue ETF (AMCA): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.